Polyethylene Glycol Elution Buffer for Monoclonal Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current Protein A affinity chromatography methods for monoclonal antibody purification face challenges with large eluate pool volumes and slow elution rates, which hinder efficient downstream processing and economic handling.
Innovation Solution
Incorporating a poly(ethylene glycol) polymer into the elution buffer for Protein A chromatography, allowing for a sharper elution peak and reduced eluate volume while maintaining yield and improving purity, with preferred concentrations between 2% to 15% by weight and molecular weights ranging from 1,000 g/mol to 10,000 g/mol.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional Protein A affinity chromatography is used for monoclonal antibody purification, then the method is well-established and reliable, but large eluate pool volumes and slow elution rates result, which hinder efficient downstream processing
Solution Approach 1:
The invention changes the chemical composition parameter of the elution buffer by adding poly(ethylene glycol) polymer at concentrations of 2-15% w/v. This parameter change modifies the elution characteristics, resulting in sharper elution peaks, faster elution rates, and reduced pool volumes while maintaining antibody yield and purity.
2Quantity of substance
If conventional Protein A affinity chromatography is used for monoclonal antibody purification, then the process is established, but large eluate pool volumes are obtained, which are undesirable for economic handling
Solution Approach 1:
By modifying the elution buffer composition to include poly(ethylene glycol) polymer, the invention achieves more efficient mass transfer and sharper elution peaks. This results in concentrated antibody eluate in smaller pool volumes, improving both the quantity characteristic and processing efficiency.
3Productivity
If poly(ethylene glycol) polymer is added to the elution buffer, then elution pool volumes are significantly reduced and yield increases by over 4%, but the buffer composition becomes more complex
Solution Approach 1:
The invention modifies the buffer composition by adding poly(ethylene glycol) polymer, which simplifies the overall process by enabling sharper elution peaks and better separation. The yield increases by over 4% compared to control conditions, and the purity is improved, making the added complexity worthwhile.
Solution Approach 2:
The elution buffer becomes a composite system combining conventional buffer components with poly(ethylene glycol) polymer. This composite composition creates synergistic effects that enhance elution performance, concentrating the antibody in smaller volumes with improved purity and yield.
4Manufacturing precision
If poly(ethylene glycol) polymer is added to the elution buffer, then purity of monoclonal antibodies is improved, but the buffer system becomes more complex
Solution Approach 1:
The addition of poly(ethylene glycol) polymer to the elution buffer modifies the chemical environment, enhancing the selectivity of the Protein A-antibody interaction and elution process. This results in improved purity of the eluted monoclonal antibodies with better separation from impurities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the volume of eluent required, increases yield by over 4%, and achieves higher purity of monoclonal antibodies, with a pH shift facilitating viral inactivation and concentrated eluate fractions.
Implementation Method 1
Protein A affinity chromatography is a well-known and widely-used tool for purifying monoclonal antibodies. Due to its specific interaction with the antibody, which take place between the Fc region of mAbs and immobilized protein A
Implementation Method 2
the addition of a poly (ethylene glycol) polymer to the elution buffer in Protein A chromatography of monoclonal antibodies leads to enhanced antibody elution resulting in significantly lower elution pool volumes
Data Source
AI summary
The invention provides a method for eluting a monoclonal antibody from a Protein A affinity chromatography column to which the monoclonal antibody is bound comprisinga) contacting the affinity chromatography column with an elution buffer comprising a poly (ethylene glycol) polymer;b) collecting one or more fractions containing the monoclonal antibody obtained from step (a)c) combining the fractions obtained from step (b) to form an elution product pool.